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Abstract
Signaling by Bone Morphogenetic Proteins (BMP) has been implicated in early lung development, adult lung homeostasis
and tissue-injury repair. However, the precise mechanism of action and the spatio-temporal pattern of BMP-signaling during
these processes remains inadequately described. To address this, we have utilized a transgenic line harboring a BMP-
responsive eGFP-reporter allele (BRE-eGFP) to construct the first detailed spatiotemporal map of canonical BMP-pathway
activation during lung development, homeostasis and adult-lung injury repair. We demonstrate that during the
pseudoglandular stage, when branching morphogenesis progresses in the developing lung, canonical BMP-pathway is
active mainly in the vascular network and the sub-epithelial smooth muscle layer of the proximal airways. Activation of the
BMP-pathway becomes evident in epithelial compartments only after embryonic day (E) 14.5 primarily in cells negative for
epithelial-lineage markers, located in the proximal portion of the airway-tree, clusters adjacent to neuro-epithelial-bodies
(NEBs) and in a substantial portion of alveolar epithelial cells. The pathway becomes activated in isolated E12.5
mesenchyme-free distal epithelial buds cultured in Matrigel suggesting that absence of reporter activity in these regions
stems from a dynamic cross-talk between endoderm and mesenchyme. Epithelial cells with activated BMP-pathway are
enriched in progenitors capable of forming colonies in three-dimensional Matrigel cultures. As lung morphogenesis
approaches completion, eGFP-expression declines and in adult lung its expression is barely detectable. However, upon
tissue-injury, either with naphthalene or bleomycin, the canonical BMP-pathways is re-activated, in bronchial or alveolar
epithelial cells respectively, in a manner reminiscent to early lung development and in tissue areas where reparatory
progenitor cells reside. Our studies illustrate the dynamic activation of canonical BMP-pathway during lung development
and adult lung tissue-repair and highlight its involvement in two important processes, namely, the early development of the
pulmonary vasculature and the management of epithelial progenitor pools both during lung development and repair of
adult lung tissue-injury.
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Introduction
Mammalian lungs are designed to optimize exposure of blood to
oxygen. To achieve this, two intertwined and highly branched
tree-like tubular systems, one conducting air and the other
conducting blood must develop in a coordinated way to generate
the millions of functional alveolar gas-exchange units [1,2,3].
Lung development in the mouse begins on embryonic day 9.5
(E9.5) when the lung primordium appears as a ventral bud in the
primitive foregut [4]. Airway branching begins around E9.5–12
and continues through the ‘‘pseudoglandular’’ [E12–E16.5] and
‘‘canalicular’’ [E16.5–E17.5] stages. Thereafter, during the
‘‘saccular’’ stage [E17.5 to postnatal day 4 (P4)] the distal airways
form the saccular units which are further subdivided by secondary
septae formed during the alveolar stage (P4–P28 in mice) to form
mature alveoli. This sequence of events is tightly controlled by the
concerted action of growth factors, transcription factors, and
mechanical forces [5,6,7].
Prominent role in the regulation of lung development and
homeostasis is played by members of the Bone Morphogenetic
Protein (BMP) family [8]. BMPs, like all other members of the
TGFb superfamily, signal via specific membrane receptors that
have serine-threonine kinase catalytic activity [9]. Functional BMP
receptor units are composed of two Type-I and two Type-II
receptor polypeptides. Four different Type-I BMP receptors
(ALK2, ALK3/BMPRIa, ALK6/BMPRIb and ALK1), and three
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Type-II receptors (BMPRII, ActRIIA and ActRIIB) have been
identified [10]. Upon ligand binding, the constitutively active
Type-II receptors phosphorylate and thus activate their Type-I
partners, which in turn phosphorylate their intracellular targets,
the receptor-regulated Smad proteins 1, 5 and 8. Phosphorylated
Smads form complexes with the ‘‘common’’ Smad4 and translo-
cate to the nucleus where they regulate expression of their target
genes, synergistically with other transcription factors [8,11]. BMPs
can also signal via Smad-independent intracellular pathways that
involve mitogen-activated protein (MAP) kinases [12,13].
Several studies using transgenic and conventional or conditional
knock-out mice have clearly demonstrated the key role played by
BMPs during early lung development [14,15,16,17,18,19,20,21].
Disruption of BMP signaling by ectopically expressing the BMP
antagonists noggin or gremlin in the lung epithelium [15,22],
inactivating BMP receptors [16] or expressing a dominant
negative form of the BMP Type-I receptor (dnALK6) result in
abnormal distal lung architecture. Remarkably, over-activation of
the BMP pathway is also incompatible with normal lung
development. Ectopic over-expression of Bmp4 in the epithelium
leads to smaller lungs and to substantially reduced epithelial cell
proliferation [14] and mice with deletion of the BMP antagonist
Follistatin-Like 1 (Fstl1) gene die at birth from respiratory distress
and show multiple defects in lung development [23,24].
Moreover, increasing evidence supports a key role for BMP
signaling angiogenesis and vasculogenesis in the lung [25,26]. A
large number of genetically modified mice with lesions in genes
encoding either BMP ligands, receptors or antagonists exhibit
defective angiogenesis. The importance of BMP signaling for the
vascular system is demonstrated by the association of mutations in
genes encoding for BMPRII and ALK1 with the development of
two genetic vascular diseases, namely, pulmonary arterial hyper-
tension and hereditary hemorrhagic telangiectasia.
The BMP signaling pathway has also been implicated in the
regulation of adult lung homeostasis and tissue repair following
injury [27,28,29,30,31]. Several BMP ligands have been found up-
regulated in allergen challenged lungs [27] and notably, ectopic
expression of gremlin by adenovirus mediated gene transfer in the
lung of adult rats causes severe pulmonary fibrosis [32] illustrating
the importance of the BMP pathway for lung homeostasis as well.
Consistently, over-expression of gremlin has been observed in
humans suffering from Idiopathic Pulmonary Fibrosis (IPF)
[28,29].
Despite the significant progress, the precise mechanism(s) by
which BMPs regulate lung development have not been fully
delineated [5]. Moreover, characterization of the mechanisms by
which BMPs affect adult lung homeostasis and tissue repair is still
rudimentary. The current study was based on the premise that
identification of the actual cellular targets of BMP mediated
signaling during lung development, homeostasis and adult lung
tissue repair will facilitate interpretation of earlier genetic studies,
guide rational targeting of BMP signaling components in future
experiments and contribute to the clarification of the mechanisms
of action of this signaling system. Therefore, utilizing a mouse
transgenic line carrying the eGFP reporter gene under the control
of a canonical BMP pathway responsive regulatory element [33]
we have constructed a detailed spatiotemporal map of canonical
BMP signaling in the lung and identified putative cellular targets of
this signaling pathway during lung development and adult lung
tissue-injury repair. Our studies suggest that canonical BMP
pathway plays key roles during early development of the
pulmonary vasculature and the management of lung epithelial
cell progenitors during late lung development and repair of adult
lung tissue injury.
Materials and Methods
Ethics Statement
Animals were housed in individually ventilated cages under
specific pathogen free conditions, in full compliance with FELASA
(Federation of Laboratory Animal Science Associations) recom-
mendations, at the Animal House Facility of the Foundation for
Biomedical Research of the Academy of Athens (Athens, Greece).
All procedures for care and treatment of animals were approved
by the Institutional Committee on Ethics of Animal Experiments
and the Greek Ministry of Agriculture (Permit Number: K/1054).
Animals
BMP-responsive eGFP expressing (BRE-eGFP) mice [33] kept
in the C57BL/6 background maintained on a 12:12 hours
light:dark cycle at the Animal Facility of the Foundation for
Biomedical Research of the Academy of Athens.
Histology
Collection of fetal lung tissues was carried out at the embryonic
(E11 and E12) pseudoglandular (E13.5 and E14.5), canalicular
(E17) and saccular (E19.5) stages. Noon of the day of the vaginal
plug was considered embryonic day (E) 0.5. Additionally, tissues
were collected on post-natal days 1 (P1), 15 (P15) and 2 months
after birth (adult). All embryonic and P1 lungs were removed
surgically, cleaned from the surrounding tissues and placed in 4%
paraformaldehyde (Merck, 104004) in PBS for 24 hours at 4uC.
For analysis of P15 and adult BRE mice the right lung-lobes were
used for RNA/Protein isolation, whereas the left lungs were gently
perfused with a mixture of 4% PFA:OCT (2:1) using a 20G
catheter (Abbocath G717-A01, 4535-20), the bronchus was ligated
and placed in 4% PFA for 24 hours at 4uC. Thereafter, the tissues
were placed in PBS with 30% sucrose for 24 hours at 4uC, washed
with PBS, embedded in OCT (Shandon Cryomatrix) and kept at
280uC until use. Cryostat sections 6–10 mm (Leica CM3050S)
were placed on polylysine or SuperFrost Plus slides (Menzel
Glaser), kept at room temperature for 3 hours with silica gel
(Merck, 101969) and then stored at 280uC. The primary
antibodies used for immunostaining were: goat anti-CC10 (Santa
Cruz, SC9773), rat anti-PECAM1 (CD31) (BD-Biosciences,
550274), rat anti-VEGFR2 (eBiosiences 14–5821), rabbit anti-
SpC (Chemicon, AB3786), rabbit anti-CGRP (Sigma-Aldrich,
C8198), mouse anti-a smooth muscle actin-Cy3 (Sigma-Aldrich,
C6198), Syrian hamster anti-T1a (DSHB 8.1.1), Sheep anti-BrdU
(Fitzgerald, 20-BS17), mouse anti-Foxj1 (generous gift of Dr. S.
Brody), mouse biotinylated anti-Muc5ac (Abcam, ab79082), anti-
SM22alpha (Abcam, ab14106) and chicken anti-GFP (Abcam,
ab13970). The secondary antibodies used were: donkey anti-goat
Texas Red (Jackson Immuno-research, 705-076-147), donkey anti-
chicken FITC (Jackson Immuno-research, 703-096-155), goat
anti-rat AlexaFluor594 (Molecular Probes, A11007), goat anti-rat
AlexaFluor647 (Molecular Probes, A21247), goat anti-Syrian
hamster AlexaFluor568 (Molecular Probes, A21112), goat anti-
Syrian hamster AlexaFluor647 (Molecular Probes, A21541),
donkey anti-rabbit Texas-Red (Jackson Immuno-research, 711-
076-152), donkey anti-sheep AlexaFluor568 (Molecular Probes,
A21099) and donkey anti-rabbit Cy5 (Jackson Immuno-research,
711-176-152). The slides were mounted using the ProLong Gold
Antifade Reagent with DAPI (Molecular Probes, P36931). Images
were captured with a Leica DMRA2 fluorescent microscope
equipped with a Leica DFC320 and DFC350 FX digital cameras
and a Leica TCS-SP5 confocal microscope (Leica Microsystems,
Wetzlar, Germany). Image analysis was performed using Adobe
Photoshop CS3, ImageJ 1.41 and Volocity LE.
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pSmad1/5/8 immuno-staining
Tissue sections prepared as described in the previous section
were treated 1.5% H2O2 in MetOH for 30 min at RT in the dark
to inactivate endogenous peroxidise. After blocking with 2%
normal donkey serum (Sigma D9663) in TBS-Tween 0.3% for
2 hours at room temperature, the sections were incubated with
rabbit anti-pSmad1/5/8 (Chemicon, ab3848) antibody overnight
at 4uC in TBS-Tween 0.3% and then incubated for 1 hour at
room temperature with the secondary anti-Rabbit HRP (Santa
Cruz, SC2301). The slides were developed using DAB chromogen
(DAKO K3468) development according to the manufacturer’s
instructions. Normal rabbit IgG fraction was used as control
primary antibody (isotype control). Nuclei were counterstained
with Mayer’s Hematoxylene.
RNA isolation and real-time quantitative PCR analysis
Total RNA from mouse lungs was isolated using the Tri-
Reagent protocol (Sigma, St. Louis, MO) and the yield and purity
of RNA was determined electrophoretically and spectrophoto-
metrically. After DNase treatment with RQ1 RNase-Free DNase
(Promega, M160A), 2 mg of RNA were reverse transcribed into
cDNA using M-MLV Reverse Transcriptase (Promega, M170B)
and random primers (Invitrogen, 58875) according to the
manufacturer’s instructions. The primer pairs for real-time PCR
were designed using Beacon Designer v7.01 software (Premier
Biosoft International, Palo Alto, CA). Sequences for the primer
pairs used are given in table S1. The PCR reactions contained
SYBRH Green ERTM qPCR Super Mix Universal (Invitrogen,
11762-500), 200 nM of each primer (Invitrogen, Carlsbad), and
0.2 ml of cDNA template in a 20 ml reaction volume. RT-qPCR
cycling parameters were initial incubation at 50uC for 2 minutes,
denaturation at 95uC for 10 minutes followed by 50 cycles of
15 seconds at 95uC and 40 seconds at 60uC. Data collection was
carried out using a Chromo4 Real-Time PCR detector (BioRad)
and analyzed with Opticon Monitor 3 expression analysis software
(BioRad). Relative levels of mRNA expression were calculated
according to the DDCt method [34].
Western Blot Analysis
For protein extraction cells were homogenized in lysis buffer
containing 50 mM Tris-Cl pH7.6, 150 mM NaCl, 1% (v/v)
Triton 6100, 5 mM EDTA pH 8.0, 1 mM PMSF, 1:25 (v/v),
Protease Inhibitor (Roche Applied Science, 11836153001), 2 mM
Na3VO4, 5 mM NaF, 2 mM Sodium Pyrophosphate, 13.3 mM b-
Glycerophosphate disodium salt. Homogenized cells were centri-
fuged at 13.000 rpm for 15 min at 4uC and protein samples were
stored at 220uC until use. For detection of pSmad1/5/8
separated proteins were transferred to Immobilon-P membrane
(Millipore, IPVH00010) and analyzed using rabbit anti-pSmad1/
5/8 (Chemicon, ab3848, 1:1000) coupled with the anti-rabbit
HRP (Santa Cruz SC2301, 1:5.000) and anti-b actin (Sigma-
Aldrich, A5316, 1:5.000) combined with the anti-mouse HRP
(Sigma-Aldrich, A4416, 1:40.000). Densitometry was done using
the ImageJ 1.41 software.
In-vivo lung tissue-injury/repair models
Female BRE-eGFP animals, between 12–16 weeks of age were
treated with naphthalene or bleomycin. For naphthalene treat-
ment, 300 mg/kg naphthalene in corn oil (vehicle) or vehicle alone
was administered by intra-peritoneal injection. Lung tissues were
collected on days 2, 3, 6, 9 post naphthalene-treatment. For
bleomycin treatment, bleomycin (0.033 Units/mouse, Nippon
Kayaku co ltd, Bleocin) diluted in PBS or PBS alone (vehicle) was
administered intra-tracheally in 30 ml total volume. Lungs were
collected on days 2, 4 and 12 post-bleomycin-treatment.
Ex-vivo culture of fetal lung explants
Transgenic E12.5 lung explants were isolated and cultured, for
8 or 24 hours, in a 1:1 mixture of DMEM: F12 (GiBCO, 11039),
supplemented with Insulin-Transferrin-Selenium (Gibco, 51300-
044) and antibiotics. Explants were placed on Nuclepore Track-
Etched Membranes (Whatman, 110414) and they were incubated
in 4-well plates (Thermo Scientific, 144444). LDN193189 (Axon
MedChem, Axon 1509) and SB431542 (Sigma-Aldrich, S4317)
were used at a concentration of 10 mM. Untreated and vehicle
(DMSO, Sigma-Aldrich, D2650) treated lungs were used as
controls. In some experiments, E12.5 lung explants were treated
with 100 ng/ml BMP4 (Peprotech, 120-05ET), or 250 ng/ml
FGF10 (Peprotech, 100-26) or 500 nM Sonic Hedgehog (Shh)
agonist-Purmorphamin (Calbiochem, 540220) for 8 hours.
Endodermal buds and distal lung mesenchyme were isolated
from E12.5 lungs as previously described [35,36]. Briefly, isolated
distal lung tips were treated for approximately 5 min with Trypsin
0.5% Pancreatin 2.5% in HBSS 16 (Gibco, 14170) on ice.
Mesenchyme was removed using 26G needles and the epithelial
buds as well as the isolated mesenchyme were placed in a (1:1)
mixture of Growth Factor Reduced Matrigel (BD Biosciences,
356230) and DMEM: F12 (GiBCO, 11039) 10% FCS (Gibco,
10500), Pen Strep (Gibco, 15070, 1:100) and incubated for
8 hours at 37uC, 5% CO2.
In vitro culture of primary adult lung cells
Adult primary lung cells were isolated as described in [37] with
small modifications. Briefly, lungs were isolated, cut in small pieces
and digested over-night at 4uC with 0.1% protease type-XIV
(Sigma-Aldrich, P5149) in Joklik’s MEM (Sigma Aldrich, 8028)
containing antibiotics (Gibco, 15070). Lung pieces were trans-
ferred in Joklik’s MEM supplemented with 10% FBS (Gibco
10500), pipetted gently several times to release cells and passed
through 70 mm cell strainer (BD Biosciences, 352350). Cells were
washed with MCDB-201 (Sigma-Aldrich, M6770) containing
Insulin-Transferrin-Selenium (Gibco, 51300-044) and viability
was measured using Trypan Blue. 106 cells (106/ml) were cultured
in 12-well plates (Nunc, 150628) coated with Bovine collagen
(Nutacon, 5409) for 24 hours. Coating was done with 100 mg/cm2
collagen, for 1 hour at 37uC. Thereafter, cultures were rinsed with
MCDB-201 to remove detached cells and 500 ml MCDB-201 with
Insulin-Transferrin-Selenium and 1 ng/ml EGF (Peprotech, 315-
09) was added. After 1 week, colonies of epithelial cells were
formed and infected with recombinant adenoviruses expressing
either constitutively-activated ALK3 (caALK3), caALK5, Smad1
or Smad3. After 48 hours incubation the treated cells were used
either for cytochemistry or for RNA extraction.
Isolation of lung subpopulations by FACS
P3 mice were anesthetized, the abdominal cavity was opened
and ventricular vein and artery were cut. The chest was opened
and the right atrium nicked. Lungs were perfused through the
right ventricle of the heart with 1 ml ice-cold 16PBS using a 26G
syringe, cut in small pieces using a razor blade and digested with
the Enzyme mix [Elastase (Sigma-Aldrich, 45124): 3 U/ml,
Collagenase: 0.1 U/ml, Dispase: 0.8 U/ml (Roche Applied
Science, 11097113001) and DnaseI 50 mg/ml (Sigma-Aldrich,
DN25] in PBS, at 37uC for 1 hour with rotation. Equal volume of
HBSS++ [HBSS 16 (Gibco, 14170), supplemented with 2% FCS
(Gibco, 10500), 0.1 M HEPES (Sigma-Aldrich, H0887) and 15%
Cell Dissociation Buffer (Gibco, 1315-016) or EGTA 2 mM] was
Canonical BMP Signaling in Murine Lung
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added. Cells were gently agitated several times, passed through a
40 mm cell strainer (BD Biosciences, 352340) and centrifuged
10 minutes at 1200 rpm, at 4uC. The supernatant was discarded
and cells were re-suspended in HBSS++ and counted with a
hemocytometer. Specific subpopulations of lung cells were isolated
using a BD FACS-Aria IIu cell sorter by staining the isolated lung
cells as previously described by Teisanu et al. [38] with
biotinylated anti-CD31 (BD Biosciences, 553371), anti-CD45
(Biolegend, 103103) and anti-CD34 (eBioscience, 13-0341-85)
combined with Streptavidin APCCy7 (Biolegend, 405208), with
anti-Sca1-Alexa Fluor647 (Biolegend, 108118) andanti-EpCam-
PECy7 (Biolegend, 118216). DAPI was included for dead cell
exclusion. The EpCampos-CD31neg-CD45neg-CD34neg cells were
separated into Sca1neg and Sca1low and each of these two
populations were separated by sorting into eGFPneg, eGFPlow
and eGFPhigh. Isolated cells were used either for further in-vitro
cultivation, RNA expression or Western Blot analysis.
In vitro cultivation of sorted epithelial cells in Matrigel was done
as previously described [38] with minor modifications. 50 ml of
26103 sorted cells and 26105 mouse lung stroma cells (MLg) were
mixed with equal volume of Growth Factor Reduced Matrigel (BD
Biosciences, 356230). Cells suspended in Matrigel were added to
the chamber of 24-well Transwell filter inserts (BD Biosciences,
353095) and placed in 24-well, flat-bottom, culture plates
containing DMEM: F12 culture medium (GiBCO, 11039)
supplemented with 5% FCS (Gibco, 10500), Insulin-Transferrin-
Figure 1. Pattern of eGFP expression in BRE-eGFP transgenic mouse lungs. A) Panoramic pictures produced by digitally merging several
images from E14.5 (merge of two images taken at 106), P1 (merge of fifty-seven images taken at 206) and adult lung (sixty-four images taken at
106). Insert in the P1 lung illustrates the high eGFP expression in trachea. Insert in adult lung image illustrates the small number of eGFPpos cells in a
large airway. B) High magnification images of E14.5, E17, P1 and adult lung tissue-sections. ‘‘Aw’’ stands for airways, ‘‘V’’ for vessels, and ‘‘Abp’’ for
airway branch-points. Insert in adult airway branch-point image depicts the small number of eGFPpos cells found in these locations. Nuclei are stained
with DAPI (blue-staining).Scale bars: 30 mm.
doi:10.1371/journal.pone.0041460.g001
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Selenium (Gibco, 51300, 1:100), Pen Strep (Gibco, 15070, 1:100),
amphotericin B (Gibco, 15290, 1:1000) and 10 mM SB431542
(Sigma-Aldrich, S4317). Culture medium was changed every other
day until day 8. SB431542 was then removed and the cultures
were maintained for an additional four days before fixing
overnight at 4uC with 4% PFA in PBS. The Matrigel was
removed by freezing-thawing and rinsing with fresh PBS. The
content of the Transwell inserts was embedded in OCT (Shandon
Cryomatrix) and 10 mm sections were prepared by cryostat (Leica
CM1950).
Although epithelial colonies developed in Matrigel even in the
absence of SB431542 its presence resulted in higher number of
larger colonies and therefore this culture system was preferred.
Treatment of the Mlg cells with SB431542 for 24 hours led to
substantial increase in FGF10 mRNA synthesis (data not shown)
suggesting that stroma cell derived FGF10 may be part of the
underlying mechanism.
Statistical analysis
One way analysis of variance (One-way ANOVA) combined
with ‘‘Bonferoni’s Multiple Comparison Test’’, was done using
GraphPad Prism. (*/#) P,0.05, (**/##) P,0.01, (***/###)
P,0.001.
Results and Discussion
Spatiotemporal pattern of expression of the BRE-eGFP
reporter during lung development
Previous studies utilizing two independent canonical BMP
pathway reporter mouse lines, one harboring a BRE-eGFP [33]
and another harboring a BRE-lacZ allele [39] have demonstrated
expression of the BRE-eGFP and BRE-lacZ reporters respectively
in the epithelium of trachea and primary-bronchi already at
around E10–E12.5. To extend these findings and map in detail the
spatiotemporal pattern of canonical BMP signaling in the lungs,
we collected lung tissues from the BRE-eGFP reporter mice at
embryonic days E11, E12, E13.5, E14.5, E16, E17.5, E19.5 and
postnatal days 1, 15 and 2 months and analyzed tissue sections for
eGFP expression. Our analysis demonstrated that the BRE-eGFP
reporter was active already at E11, reached maximal levels around
birth, thereafter declining to minimal levels in the adult (Figure 1
and Figure S1).
Around E11, eGFP expression was confined to the endothelial
cells of the large pulmonary vessels, and the developing vascular
network in the parenchyma. A very small fraction of sub-epithelial
smooth muscle cells (SMCs) expressed very low levels of eGFP at
E12 (Figure S1). However, from E13.5 onwards robust eGFP
expression was detected in sub-epithelial SMCs located at the
proximal regions of the developing airways (Figures 1 and Figures
S1 and S2).
From E16 onwards, expression of eGFP was detected in both
proximal and distal epithelial compartments.In the proximal
epithelium (i.e. the developing airways) eGFP expression exhibited
a proximal-distal axis pattern, with high eGFP expression in
bronchi and large airways and surprisingly no expression at the
distal portion of the growing airway tree. Interestingly, isolated
clusters of eGFPpos cells were observed at the tips of airway
branch-points. In the distal lung compartment, eGFP expression
was detected in cuboidal epithelial cells of the developing saccules
(Figure 1B). As lung morphogenesis approached completion, the
eGFP signal was reduced and in adult mice,(,2 months old), few
eGFPpos cells were detected scattered in the epithelium of bronchi
and large airways, in the alveolar compartment and in a
subpopulation of cardiac cells in the outer layer of the tunica media
of the pulmonary veins (Figure 1B) [40].
Expression of the BRE-eGFP reporter in the developing
lung mirrors faithfully activation of the canonical BMP
pathway
Although the capacity of BRE element to monitor BMP
mediated transcriptional activation in-vivo has been demonstrated
previously [33,39,41], additional studies were undertaken to
further increase confidence with respect to transgene expression
in the lung. The kinetics of mRNA expression for eGFP and the
BMP target gene Id1 were analyzed by quantitative PCR. EGFP
and Id1 mRNA levels followed similar kinetics to eGFP protein
expression, reaching maximum levels around birth (Figure 2A). P1
lungs were therefore enzymatically digested and lung cells were
separated by cell sorting on the basis of eGFP expression into
eGFP negative (eGFPneg), eGFPlow (eGFPlow) and eGFP high
(eGFPhigh) cells (Figure 2B). Western blot analysis of protein
extracts from the isolated population demonstrated good correla-
tion between expression of eGFP and levels of pSmad1/5/8
(Figure 2C, D). Analysis of the mRNA levels for eGFP and BMP-
regulated target genes such as Smad6, Id1 and Id3 demonstrated
very good correlation between the level of eGFP expression and
the activation of known BMP targets (Figure 2E). Interestingly,
expression of Id2 mRNA did not correlate with levels of eGFP
expression. Furthermore, treatment of embryonic lung explants ex-
vivo with either BMP- or TGFb-receptor inhibitors resulted in
either suppression or augmentation of BRE-eGFP transgene
expression, respectively (see below Figure 3B). Moreover, treat-
ment of embryonic lung explants with FGF10, a known inducer of
BMP4 production by distal endodermal cells, or recombinant
BMP4 resulted in substantial up-regulation of eGFP expression
(Figure S3). Treatment of the lung explants with purmorphamin, a
Shh agonist, resulted in redistribution of the eGFP staining pattern
that involved a small increase of eGFP expression in a narrow
zone of sub-mesothelial cells and a reduction of eGFP expression
in the more central parts of the mesenchyme. This pattern of
expression could stem from a Shh mediated reduction in FGF10
synthesis by mesenchymal cells [35] that in turn leads to a more
confined BMP expression zone.
Too further validate the BRE-eGFP reporter animals and assess
its sensitivity in comparison to staining tissues for nuclear
pSmad1/5/8 by immuno-histochemistry, we stained adjacent
tissue sections of P1 lungs, the developmental stage demonstrating
maximal BRE-eGFP reporter activity, with anti-eGFP and anti-
pSmad1/5/8 antibodies. As shown in Figure S4, nuclear
pSmad1/5/8 was detected in regions with intense eGFP
immuno-staining demonstrating consistency between BRE-eGFP
reporter activity and pSmad1/5/8 immuno-staining (figure S4).
Unfortunately, in our hands the anti-pSmad1,5,8 reagents we have
analyzed so far were unable to detect pSmad1/5/8 in lung tissues
from embryos before stage E19.5 and thus we were not able to
confirm correlation of eGFP and pSmad1/5/8 at earlier
developmental stages. A number of studies have indicated that
the value of measuring pSmad1/5/8 as the sole indicator for
canonical BMP pathway activation is questionable since presence
of pSmad1/5/8 does not necessarily lead to transcriptional activity
of BMP target genes. Canonical BMP pathway activity is known to
be regulated by cell type-specific Smad-interacting transcription
factors, co-activators and co-repressors. For example Tbx1 can
bind to Smad1, interfere with Smad1/Smad4 interaction and
decrease BMP transcriptional activity without affecting the
amount of pSmad1/5/8 in the responding cell [42]. Furthermore,
Leeuwis et al. [41] demonstrated that in the kidney of BRE-eGFP
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animals, whereas the expression pattern of BRE-eGFP exhibited
excellent correlation with the expression of the BMP7 and the
BMP target genes Id1, and Smad6, in contrast pSmad1/5/8
exhibited a brought expression pattern that did not correlate with
the expression of BRE-eGFP, BMP7, Id1 or Smad6. Therefore, a
safer assessment of canonical BMP pathway should combine
analysis of several known BMP target genes and pSmad1/5/8
immuno-stainings when this is technically possible. Collectively,
the analysis by Monteiro et al. [33], Leeuwis et al. [41] and the
results described herein indicate that the BRE-eGFP transgenic
line reports quite faithfully activation of the canonical BMP
pathway in-vivo and ex-vivo and thus it provides an additional
method for assessing potential canonical BMP pathway activation.
Canonical BMP-pathway is activated in the developing
vascular and sub-epithelial smooth muscle networks
during early lung development
To identify the putative cellular targets of canonical BMP
signaling, tissue sections collected from lungs at different
developmental stages were stained with antibodies specific for
appropriate cellular markers. Double immunostaining for eGFP
and CD31 (PECAM-1), a surface marker of mature endothelium,
or VEGFR2, a surface marker of vascular progenitor cells (Figure
S1), demonstrated that the majority of CD31pos or VEGFR2pos
cells at E12, E14.5 and E17 were also eGFPpos (Figure 3A),
confirming that the network of eGFPpos cells in the parenchyma is
composed of vascular cells and that the canonical BMP pathway is
activated during the establishment of the vascular network in the
developing lung. At P1, ,40% of the CD31pos cells were eGFPpos,
from P15 onwards the number of eGFPpos-CD31pos cells declined
and in the adult they were undetectable. EGFP expression with
similar kinetics was observed in the endothelial cells lining the
large blood vessels (Figure 3A). Very few eGFPpos alpha smooth
muscle actin (aSMA) double positive cells were found in the walls
of the vessels (Figure 3A, white arrow in P1 vessel).
To validate the functional significance of BMP signaling for the
development of the vascular network of the developing lung, ex-vivo
cultures of E12 lung explants were treated with the respective
BMP- or TGFb/Activin-receptor inhibitors LDN193189 and
SB431542. Treatment of lung explants for 24 hours with
SB431542 led to a substantial increase in eGFP, Id1, and
FGF10 mRNA expression, whereas treatment with LDN193189
led to a decrease ineGFP, Id1 and FGF10 mRNA expression and
an increase, probably compensatory, in BMP4 and VEGFa
mRNA expression (Figure 3B and D). Remarkably, even 8 hours
of treatment with the SB431542 led to an increase in the density of
the CD31pos network and a more pronounced increase in the
eGFPpos network, whereas, similar treatment with LDN193189
Figure 2. Expression of the BRE-eGFP reporter in the developing lung mirrors faithfully activation of the canonical BMP pathway. A)
Kinetics of eGFP and Id1 mRNA expression levels during lung development analysed by Real-Time PCR. Values represent mean 6 SEM of five
individually analyzed animals. B) eGFP profile of enzymatically digested P1 lungs. The gates used to separate lung cells by sorting into eGFPneg,
eGFPmed and eGFPhigh are indicated. C) Representative Western-blotting of proteins prepared from sorted populations with an anti-pSmad1/5/8
antibody. D) Quantitation of the pSmad1/5/8 relative to the eGFPneg group.Values represent mean 6 SEM of two independent experiments. E)
Analysis of mRNA expression levels for eGFP, Smad6, Id1, Id3 and Id2in sorted cells. Values represent mean 6 SEM of seven individually analyzed
experiments. Groups were compared using one-way analysis of variance (ANOVA) with Bonferonis’s post-hoc analysis. *P,0.05, **P,0.01 and
***P,0.001.
doi:10.1371/journal.pone.0041460.g002
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led to reduction in the density and connectivity of the eGFPpos and
CD31pos cells (Figure 3C).
Collectively, these findings indicate that during the pseudo-
glandular stage, in the course of which most of the stereotypical
branching morphogenesis is thought to take place, an important
target of canonical BMP signaling in the lung is the developing
pulmonary vasculature.
Strong eGFP expression was detected in the developingsub-
epithelial SMC layer of the proximal airways from E14.5 to P1
(Figure 3A and Figures S1 & S2). The eGFP expression, which
interestingly involved only a portion of the sub-epithelial SMCs,
was undetectable by P15. It has been proposed that sub-epithelial
SMCs originate from a pool of sub-mesothelial, FGF10-express-
ing, mesenchymal cells. Under the influence of several signalling
pathways, such as those mediated by FGF, BMP, Shh, and Wnt,
these cells proliferate and passively translocate to surround the
proximal portion of the developing airway tree [35,43,44,45,46].
http://www.sciencedirect.com/science/article/pii/S0012160611
010189 - bb0125To map more precisely the temporal activation
of the BRE-eGFP reporter during development of the sub-
epithelial SMC compartment we isolated P11, P12 and P13.5
lungs from the BRE-eGFP reporter animals and analysed co-
expression of eGFP and SM22a, a marker of both primitive and
mature SMCs [47], or aSMA a marker of more differentiated
Figure 3. Canonical BMP-pathway is active in the developing vascular and sub-epithelial smooth muscle networks. A) Confocal
images of tissues from different developmental stages stained with antibodies to eGFP and CD31 (parenchyma and blood-vessels), and eGFP and
aSMA (blood-vessels and large-airways). Nuclei were counterstained with DAPI. Representative eGFPpos cells in the different tissue compartments are
shown with arrows. Green arrows depict eGFPpos cells, whereas yellow arrows depict eGFPpos-CD31pos or eGFPpos-aSMApos cells. A white arrow in the
P1 vessel indicates a rare eGFPpos-aSMApos vascular smooth-muscle cells. ‘‘Aw’’ defines airways and ‘‘V’’ vessels. Scale bar: 20 mm. B) Whole E12 lung-
explants, cultured on Nuclepore membranes, were treated with vehicle, SB431542, or LDN193189. Upper panel shows transmitted light images of
representative explants. Lower panel shows eGFP expression in the same explants. C) Confocal images of tissue-sections from lung-explants treated
with vehicle, SB431542 or LDN193189 for 8-hours and stained with antibodies to eGFP, CD31 and aSMA. Nuclei were counter-stained with DAPI. D)
Quantitative-PCR analysis of eGFP, Id1, FGF10, BMP4 and VEGFa mRNA expression in vehicle or inhibitor-treated lung explants. Values represent
mean 6 SEM of six SB431542-treated, seven LDN193189-treated and thirteen vehicle treated, individually analyzed explants per group, compared
using one-way analysis of variance (ANOVA) with Bonferoni’s post-hoc analysis. *P,0.05, **P,0.01 (vehicle vs inhibitor treated groups) and #P,0.05,
##P,0.01, ###P,0.001 (SB vs LDN treated groups).
doi:10.1371/journal.pone.0041460.g003
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SMCs. As shown in Figure S1B, SM22a expression was
observed in a sub-epithelial population of cells around the
developing proximal airways already at embryonic stage E11,
aSMA expression was evident only in the most proximal
portion of the SM22apos zone and eGFP expression was clearly
detected in the aSMApos zone only after embryonic stage E13.5
(very few aSMApos cells expressed very low levels of eGFP at
E12). These findings are consistent with the notion that
canonical BMP signalling does not involve primitive SMCs
but rather mature aSMA expressing sub-epithelial SMCs.
Canonical BMP pathway activation in developing airway
epithelial cells
Although strong BRE activity was detected in the trachea and
primary bronchi as early as E10–E12.5 [33], consistent with the
demonstrated role of BMP signaling in trachea development
[48,49], BMP-driven eGFP-expression was not detected in the
epithelial compartments of the interlobular airways before the
canalicular stage of lung development. As shown in Figures 1 and
4A, minimal eGFP expression was detected around E14.5 in the
large airways, and only after E17 strong eGFP signal was detected
in cartilaginous and large airways following a proximal-distal axis
pattern, with more intense signal in the proximal part of the
bronchial tree. Immunostaining of BRE-eGFP lung tissue sections
with an antibody specific for the Clara cell specific differentiation
marker Scgb1a1/CCSP/CC10 (hereafter referred to as CC10),
revealed expression of the eGFP reporter from E17.5 and
onwards, in luminal cells of the developing airways. Strong
CC10 expression was detected around E19.5, approximately two
days after the onset of eGFP expression in the airway epithelium
(Figure 4A) CC10 and eGFP exhibited partially overlapping zones
of expression, with eGFP being highly expressed in the proximal
portion and CC10 highly expressed in the distal portion of the
developing airway tree. A zone of eGFPpos-CC10pos cells appeared
to separate the CC10pos epithelial population from the eGFPpos
airway regions. Postnatal expansion of CC10pos regions in the
conducting airways was accompanied by a gradual reduction of
the eGFPpos regions (Figure 4A).
Interestingly, regions of airways exhibiting enhanced eGFP
expression were detected close to the tips of airway branch-points
in close proximity to neuro-epithelial bodies (NEBs). Analysis of
the eGFP expression in relation to CC10 and CGRP, a
differentiation marker of neuro-epithelial cells, revealed that
eGFPpos-CC10lowcells formed ‘‘caps’’ over clusters of CGRPpos
cells. From E19.5, the eGFPpos-CC10low‘‘cap’’ cells (green-arrows
in Figure 4B) were separated from the eGFPneg-CC10pos cells by a
zone of double positive epithelial cells (yellow-arrows in Figure 4B).
Notably, the zone of eGFPpos-CC10poscells coincided with zones
richin NEBs (Figure S5). From P15 and beyond, the only NEB-
associated eGFPpos cells were CGRPpos neuro-epithelial cells
(blue-arrows in Figure 4B).
As the majority of eGFPpos cells did not express the marker for
secretory airway epithelium (CC10), their possible relationship to
ciliated airway epithelial cells was investigated by staining with
antibodies for Foxj1 a ciliated cell specific differentiation marker.
As shown in Figure S6, a remarkably small portion of eGFPpos
cells were FoxJ1pos (yellow-arrows in Figure S6).
Two alternative models have been proposed regarding the role
of BMP signalling during lung branching morphogenesis. One
model suggests that mesenchymal derived FGF10 induces Bmp4
expression by the distal bud epithelium to limit, in an autocrine
manner, Fgf10-mediated bud outgrowth [45,50]. The other
model, based on the differential response of the distal epithelial
buds to BMP4 in the presence or absence of mesenchyme,
proposes that Bmp4 produced by the distal epithelium acts in an
autocrine manner to limit proliferation of distal epithelial buds,
and in a paracrine manner, on the adjacent mesenchyme, to
induce production of a mesenchymal signal that enhances
proliferation of distal epithelial buds [51]. Thus, according to
the latter model the negative or positive effect of BMP signalling
on branching is the outcome of a dynamic balance between
negative autocrine and positive paracrine mechanism.
The absence of eGFP reporter activation in the distal buds of
the branching airway tree (Figures 1 and 4) prompted us to
investigate whether this is the result of an intrinsic inability of the
distal epithelium to activate the canonical BMP pathway or, in
accordance to the second model, the result of a dynamic interplay
with the adjacent mesenchyme. Therefore, mesenchyme free distal
epithelial buds and epithelial free mesenchyme were isolated as
previously described [35,36] and cultured in Matrigel. Remark-
ably, within 8 hours of incubation, the BRE-eGFP reporter was
strongly up-regulated in the mesenchyme-free epithelial buds and
conversely it exhibited a tendency for decline in the isolated
mesenchyme (Figure 5). These findings are consistent with the
model of Bragg et al. [51] and moreover suggest that the elusive,
mesenchyme derived, epithelial growth promoting signal could
simply act by negatively regulating activation of the canonical
BMP pathway in the distal epithelium buds.
Collectively, the above findings demonstrate that activation of
the canonical BMP pathway in airway epithelial cells coincides
with the beginning of the canalicular stage, when the develop-
mental plan of the lung shifts from branching morphogenesis to
the development of distinct respiratory epithelial cell compart-
ments [52]. Keeping in mind that gas conducting airways and
blood conducting vessels need to develop in a coordinated manner
and be properly juxtaposed to support optimal gas-exchange in the
adult, it is understandable that the tips of developing airways
should reciprocally exchange growth, differentiation or guidance
signals with the developing vasculature and other mesenchymal
cells to ensure coordinated development and spatial integration of
these two branching systems. The finding that disruption of the
vascular network in growing lung explants affects branching
morphogenesis by reducing primarily ‘‘orthogonal bifurcations’’ of
the epithelial tubules [53,54] and the findings presented herein
demonstrating the influence of the adjacent mesenchyme on the
activation of the canonical BMP pathway reporter (Figure 5)
illustrates the importance of the crosstalk between epithelial and
vascular cells during early lung development.
It should be pointed out that due to our failure to successfully
apply anti-pSmad1/5/8 immuno-histochemistry in tissues from
embryos earlier than stage E19.5, we cannot conclusively rule out
for the moment activation of the canonical BMP pathway at the
tips of the early branching endoderm. Further studies will be
required to assess whether the BRE-eGFP reporter is not active in
the distal endoderm because: a) non-canonical BMP pathways are
primarily involved; b) the canonical BMP pathway is active
however, does not reach the activation threshold required to
activate the BRE-eGFP reporter; or c) that the dynamic balance
between the mesenchyme and endoderm which keeps the BRE-
eGFP reporter inactive most of the time (Figure 5), allows at
critical points along the branching process transient spikes of
canonical BMP pathway signaling to reach the nucleus and
regulate expression of target genes.
Canonical BMP pathway activation in alveolar epithelial
cells
Over-expression of BMP ligands or inactivation of BMP
receptors in the distal part of the developing lung leads to
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dramatic defects in alveolar development [14,16,18,19]. Since
eGFP expression was highly increased in lung parenchyma of the
BRE-eGFP mice during the saccular and alveolar stages, the
period during which functional alveoli are formed, we character-
ized the nature of the eGFPpos cells in this part of the developing
lung. Tissue sections from different developmental stages were
analyzed by co-staining for eGFP and pro-surfactant protein C
(pro-SpC), a marker of type-II pneumocytes. As shown in figure 6
and Figure S2, eGFP staining during the pseudoglandular stage
was confined to endothelial cells and peri-bronchial smooth
muscle cells of the proximal airways. Pro-SpCpos epithelial cells in
the distal airways were uniformly eGFPneg at this developmental
stage (Figure S2).In contrast, starting at the canalicular stage (E17)
and persisting until approximately P15, a population of eGFPpos-
pro-SpCpos cells emerged in the distal lung compartments
(Figure 6A).The SpCpos cells at this stage of development are
thought to be immature type-II pneumocytes [55]. Morphometric
analysis demonstrated that during the saccular and alveolar stages,
approximately half of the pro-SpCpos alveolar cells were eGFPpos.
Adult tissues, in which alveolarization was complete, contained a
very small number of eGFPpos-pro-SpCpos alveolar cells (,0.5–
1%) (Figure 6B). High resolution confocal microscopy analysis
revealed that at all the developmental stages analyzed only a very
small portion of type-I pneumocytes were eGFPpos (Figure S7).
Interestingly, ectopic over-expression of a constitutive ALK3 in
cultures of adult primary pulmonary cells resulted in increased
pro-SpC (,6-fold) and Id1 (,15 fold) mRNA levels, in
comparison to the untreated or ALK5ca treated groups
(Figure 6C) further implicating canonical BMP-signaling in the
physiology of type-II pneumocytes.
The sequential appearance of eGFPneg-SpCpos (immature type-
II pneumocytes), eGFPpos-SpCpos and eGFPneg-SpCpos (mature
type-II pneumocytes) may suggest that the eGFPpos-SpCpos
population is an intermediate step through which immature
type-II pneumocytes must pass before developing into mature
functionally competent type-II pneumocytes. This conclusion is
compatible with the finding that mice with canonical BMP
pathway disrupted due to deletion of the Smad1 gene accumulate
in their developing lungs high numbers of periodic acid-Schiff
(PAS) positive immature type-II pneumocytes [19].
The above findings indicate that during the cannalicular stage,
an important target of canonical BMP signaling in the distal lung
compartment is the developing type-II pneumocyte population.
This could explain the dramatic distal lung phenotype of animals
with disrupted BMP signaling in the distal lung epithelium
[15,16,18,19].
It is very intriguing that with the beginning of the canalicular
stage, when the developmental plan of the lung shifts from
branching morphogenesis to the development of distinct respira-
tory epithelial cell compartments [52], the BMP-responsive eGFP
reporter is activated in two epithelial domains, namely, the
proximal airways and the distal developing alveolar sacs. The
Figure 4. Activation of canonical BMP pathway in developing airway epithelial cells. A) Confocal images of tissue sections of lungs
collected from E17, E19.5, P1, P15 and adult BRE-eGFP animals, stained for eGFP (green-staining) and CC10 (red-staining). Yellow arrows depict
eGFPpos-CC10pos epithelial cells found in the borders between the proximal eGFPpos zone (cartilaginous and large-airways) and the distal CC10pos
zone of the airways (intermediate airways and terminal bronchioles). Nuclei were counter-stained with DAPI.Scale bar: 25 mm. B) Similar tissue section
as above stained for eGFP, CC10, CGRP and DAPI demonstrating eGFP and CC10 staining around solitary and airway branch-point associated NEBs.
Colors are as labeled in the figures. Green and yellow arrows depict representative eGFPpos-CC10neg and eGFPpos-CC10pos epithelial cells respectively.
White and blue arrows in the P15 and adult lung sections depict representative eGFPneg-CGRPpos and eGFPpos-CGRPpos neuro-endocrine cells
respectively. The eGFP and CC10/CGRP channels of the E19.5 airway branching point are shown separately to illustrate the CC10low phenotype of the
NEB’s eGFPpos epithelial ‘‘cap’’. Cropped images of the eGFP channel illustrate the eGFPpos-CGRPpos cells in the adult solitary NEB and in the P15 and
adult branching point associated NEBs. Scale bars: 25 mm.
doi:10.1371/journal.pone.0041460.g004
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Figure 5. The BRE-eGFP reporter is activated in mesenchyme-free epithelial buds cultured in Matrigel. Distal endodermal buds and
mesenchyme were isolated by micro-dissection from E12.5 BRE-eGFP embryos and cultured for 8 hours in Matrigel. Bright field and fluorescence
images from the same colonies were acquired at time 0 and 8 hours. Note the strong re-activation of the BRE-eGFP reporter in mesenchyme-free
endodermal buds and the reduced (diffuse) eGFP expression in the isolated mesenchyme after 8 hours in culture. Dotted lines indicate the location
of the epithelial buds in the eGFP images and small clusters of cells with reduced eGFP expression are indicated with arrows.
doi:10.1371/journal.pone.0041460.g005
Figure 6. Canonical BMP pathway activation in alveolar epithelial cells. A) Confocal images of lung tissue-sections collected from E14.5, E17,
E19.5, P1, P15 and adult BRE-eGFP transgenic animals stained for eGFP and pro-SpC. Red and yellow arrows depict eGFPneg-SpCpos and eGFPpos-
SpCpos cells respectively. The sections were counterstained with DAPI. Scale bar: 20 mm. B) Morphometric analysis of SpCpos-eGFPneg and
SpCposeGFPpos cells in distal lung compartment. C) Adult lung cells were treated with combinations of ALK3 and Smad1, or ALK5 and Smad3
adenoviruses. Messenger RNA levels of eGFP, Id1 and SpC were analyzed 48 hours later by quantitative-PCR. Values represent mean 6 SEM of 8
individually analyzed cultures per group compared to the untreated group using one-way analysis of variance (ANOVA) with Bonferonni’s post-hoc
analysis. ***P,0.001 and ###P,0.001 (ALK3/Smad1 vs ALK5/Smad3).
doi:10.1371/journal.pone.0041460.g006
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conclusion that canonical BMP signaling becomes crucial for lung
epithelial cell development at the cannalicular stage is consistent
with earlier genetic studies demonstrating that deletion of Bmpr1
[16,18] or Smad1 [19] and ectopic expression of negative
regulators of BMP signaling such as XNoggin and dominant-
negative ALK6 [15] by SpC-promoter-driven expression, resulted
in defects in lung development visible only around E15-E16, i.e.
after completion of the branching morphogenesis.
The eGFPpos epithelial compartment is enriched for
epithelial progenitors capable in forming colonies in
Matrigel
The localization of eGFPpos cells in the vicinity of NEBs and
the minimal overlap between cells expressing eGFP and markers
for specialized secretory (CC10) or ciliated cells (FoxJ1) prompted
us to investigate whether active canonical BMP signaling may
define cells with an immature progenitor phenotype. Thus, a
single two hour pulse of BrdU was given to pregnant mothers at
E17 to label cycling epithelial cells which were subsequently
detected by staining with anti-BrdU antibodies. BrdUpos cells
accounted for ,6.7% of the surface airway epithelium in
conducting airways and were uniformly distributed throughout
the airway tree (Figure 7A). This pattern is compatible with the
findings of Giangreco et al. [56] and Rawlins et al. [57]
demonstrating that randomly distributed progenitor cells con-
tribute to normal epithelial homeostasis. Of the BrdUpos cells
,77.8% were eGFPneg and ,22.2% were eGFPpos, indicating
that both populations contribute to the expansion of the airway
epithelial compartment (Figure 7B). Despite the dominance of the
eGFPneg-BrdUpos cells (in absolute numbers), ,13.4% of the
eGFPpos were BrdUpos, compared to ,5.5% for the eGFPneg cells
(Figure 7C).
To further compare the proliferative potential of the eGFPpos
and eGFPneg cells different epithelial populations were isolated
from dissociated lung tissue by cell sorting and analyzedin-vitro for
colony-forming ability. Following a previously described protocol
[38], EpCAMpos, Lineage negative (i.e. CD45neg-CD31neg-
CD34neg) cells from BRE-eGFP transgenic animals were subdi-
vided into Sca1neg and Sca1low cells. Finally the Sca1neg and
Sca1low cells were separated by sorting into eGFPneg, eGFPlow and
eGFPhigh cells respectively (Figure 7D). Isolated cells were co-
cultured with MLg feeder cells in a 3-dimensional Matrigel culture
system [38]with a modification developed by some of us (HC and
BRS) that involved co-culture of the cells in Matrigel for eight days
in the presence of the TGFb receptor inhibitor SB431542
(10 mM), followed by an additional four days in the absence of
inhibitor.
Linneg-EpCAMpos-Sca1lowcells cultured in this way, in agree-
ment with previous reports [58], gave rise primarily to large cystic
epithelial colonies and Linneg-EpCAMpos-Sca1neg cells gave rise
almost exclusively to smaller compact epithelial colonies
(Figure 7E). The clonogenic capacity of both Sca1low and Sca1neg
cells correlated with the expression levels of the BRE-eGFP
reporter with the corresponding eGFPhigh populations exhibiting
highest clonogenic capacity (Figure 7F). Previous studies have
suggested that cystic colonies derived from Linneg-EpCAMpos-
Sca1low cells contain progenitors of airway epithelial cells
(Muc5Acpos), whereas, the compact colonies derived from
Linneg-EpCAMpos-Sca1neg cells contain primarily SpCpos alveolar
progenitors [58]. Consistently, as shown in Figure 7G, whereas all
compact colonies derived from the Sca1neg subpopulations
exhibited a similar SpCpos-Muc5Acneg staining pattern, the large
cystic colonies derived from the Sca1low subpopulations exhibited
a more heterogeneous pattern of staining with approximately half
of them expressing Muc5Ac and half of them expressing SpC.
It is worth noting that adult Linneg-EpCAMpos-Sca1neg epithe-
lial cells have very low clonogenic capacity in Matrigel [38]. The
development of colonies fromLinneg-EpCAMpos-Sca1negcells in the
current study is most probably due to the fact that the analysis was
done with P3 lungs which were still undergoing intense alveolar
development.
Previous studies have provided evidence for two types of airway
epithelial progenitors, one randomly distributed in the airways that
maintains normal epithelial homeostasis and responds to minor
injuries of the epithelium, and a second, associated with previously
described progenitor cell niches that can renew depleted Clara
cells upon severe epithelial injury [38,56]. The randomly
distributed eGFPneg-BrdUpos cells detected in the developing
lungs (Figure 7A) could represent the former type whereas the
eGFPpos epithelial cells could represent the latter type of
progenitors. Once lung development is completed, the homeo-
static, low turnover, maintenance of the epithelial population can
be supported by the distributed Clara cells [38,56] and thus active
BMP signaling may not be required any longer. The decline in
eGFP expression in the lungs of the adult BRE-eGFP transgenics
may reflect just that.
Figure 7. The eGFPpos epithelial compartments are enriched for in-vitro colony-forming epithelial progenitors. A) Confocal image of
an E17 lung tissue-section collected after a two-hour pulse with BrdU, stained for eGFP, BrdU, CGRP and DAPI. Colors are as labeled in the figures.
Proliferating BrdUpos cells can be seen scattered all across the respiratory tree. B) Percentage of cells with the indicated characteristics in 8000–9000
airway epithelial cells counted per animal. C) Percentage of proliferating cells within each of the indicated epithelial population. Values represent
mean 6 SEM of six individually-analyzed animals. eGFPpos and eGFPneg groups compared to the ‘‘total’’ group using one-way analysis of variance
(ANOVA) with Bonferoni’s post-hoc test. D) Isolation of epithelial cell sub-populations by cell sorting. Single cell populations were prepared for cell
sorting as described in Materials and Methods. Viable Linneg cells (gate P4) were subdivided into EpCAMpos-Sca1neg (gate P5) and EpCAMpos-Sca1low
(gate P6). EGFPneg, eGFPlow and eGFPhigh cells from either EpCAMpos sub-population were isolated using a FACS ARIA IIu cells sorter. The purities of
the sorted sub-populations were: for Sca1neg: eGFPneg (gate P7, ,90%), eGFPlow (gate P8, ,85%), eGFPhigh (gate P9, ,90%); for Sca1low: eGFPneg
(gate P10, ,95%), eGFPlow (gate P11, ,92%), eGFPhigh (gate P12, ,98%). E) Representative bright field and fluorescence (eGFP) images of Day 8
Matrigel cultures seeded with 2000 cells sorted with the gates P7–P12 and co-cultured with Mlg stroma cells in the presence of 10 mM SB431542.
Note the dominance of large cystic colonies in the Sca1low sub-populations and the dominance of smaller compact colonies in the Sca1neg sub-
populations. After 8 days in culture the vast majority of the colonies from the eGFPlow cultured cells were eGFPneg. Almost half of the colonies from
the eGFPhigh cultured cells were eGFPneg. The frequency of eGFPpos cells in the eGFPpos colonies ranged from 10–100%. F) Quantitation of the
colonies produced in Matrigel by 2000 cells from each indicated sorted sub-population.Values represent mean 6 SEM of eight independent
experiments compared withone-way analysis of variance (ANOVA) with Bonferoni’s post-hoc test. **P,0.01, ***P,0.001 (compared to the GFPneg
group) and ###P,0.001 (eGFPlowvs eGFPhigh group). G) SB431542 was removed on day 8 and the Matrigel cultures were incubated for additional
four days. Sections of the Matrigel cultures, prepared as described in Materials and Methods, were stained with anti-Muc5Ac and anti-SpC antibodies.
All compact colonies derived from the Sca1neg sorted cells were SpCpos-Muc5Acneg. The cystic colonies derived from the Sca1low cells after the
additional four days culture in the absence of SBSB431542contained Muc5Ac (,50%) and SpC (,50%) positive colonies. No Muc5Ac positive colonies
were found in cultures with similar cells analyzed on day 8 before the removal of the inhibitor.
doi:10.1371/journal.pone.0041460.g007
Canonical BMP Signaling in Murine Lung
PLOS ONE | www.plosone.org 12 August 2012 | Volume 7 | Issue 8 | e41460
Reactivation of the BRE-eGFP reporter in adult lung after
tissue injury suggests an active role of BMP-signaling in
adult lung repair after injury
The dramatic decline of eGFP expression in the adult lung of
the BRE-eGFP reporter mice and the association of eGFP
expression with the epithelial progenitor pool prompted us to
investigate whether the reporter was reactivated in adult lung
during injury and repair. Adult BRE-eGFP animals were analysed
in two established models of lung tissue injury and repair, namely
the naphthalene and bleomycin induce lung injury models.
Naphthalene treatment causes selective depletion of Clara cells
in the airways [59]. In contrast, bleomycin causes epithelial cell
death, acute inflammation and fibro-proliferative remodeling of
the peripheral lung [60]. Immuno-staining for CC10 and CGRP
demonstrated that by day 3, naphthalene treatment had caused a
large reduction in CC10pos cells in the airways, an increase in the
number of CGRPpos cells per NEB, and a substantial increase in
BRE-eGFP reporter activity at airway branch-points and terminal
bronchioles (Figure 8A).This pattern of CC10 localization and
eGFP reporter expression corresponds with previously determined
anatomic locations that maintain chemically resistant epithelial
progenitor cells [61,62,63,64].
Analysis at different time points after naphthalene-treatment
demonstrated a gradual increase in the number of eGFPpos
bronchial epithelial cells that was evident on day 2 and maximum
increase of 15-fold over control levels by day-9 post-naphthalene
treatment (Figure 8B). Up to day-2, the increase in eGFPpos airway
epithelial cell numbers involved CGRPpos and CGRPneg-CC10low-
cells (Figures 8C and D). Thereafter, although the total number of
eGFPpos-CGRPpos cells remained stable from days 2–9, a wave of
eGFPpos-CC10low-CGRPneg cells that reached maximum around
day 3 was followed by a wave of eGFPpos-CC10pos cells that
reached plateau around day-9 (Figure 8D).
Interestingly, the distribution of eGFP and CC10 expression
recapitulated the pattern observed during early lung development
i.e. eGFPpos-CC10pos cells separating eGFPpos-CC10low from
apparently newly formed eGFPneg-CC10pos cells. The kinetics of
appearance and relative localization of these cells within the tissues
are consistent with the notion that they may represent sequential
stages of development from the eGFPpos-CC10low to the eGFPneg-
CC10pos phenotype.
Bleomycin is an anti-cancer drug, which induces lung injury
and fibrosis [60]. As shown in Figures 9A and 9B, treatment of
adult BRE-eGFP animals by intra-tracheal administration of
bleomycin resulted in substantial reactivation of the eGFP reporter
in type-II pneumocytes (Pro-SpCpos). During the first days of
treatment the eGFPpos cells were primarily cuboidal SpCpos cells.
From day-4 onwards both cuboidal and squamous eGFPpos cells
were found in the alveolar regions. Interestingly, the squamous
eGFPpos cells were T1a-expressing type-I pneumocytes and were
Figure 8. The eGFP reporter is reactivated in the airways of BRE-eGFP transgenic animals after injury of their bronchial epithelium
by naphthalene. A) Confocal images of lung tissues collected from vehicle (corn oil) or naphthalene-treated BRE-eGFP transgenic animals, 3 and 9
days post-treatment, stained for eGFP, CC10 and CGRP. Colors are as labeled in the figure. Nuclei were counterstained with DAPI. Reactivation of the
eGFP reporter is shown in the vicinity of NEBs or terminal-bronchiolar regions. Scale: 40 mm. B) Morphometric analysis of eGFPpos cells in
naphthalene-treated animals expressed as fold increase over the vehicle-treated controls. C) Morphometric analysis illustrating the increased
frequency of eGFP expression among the CGRPpos cells. Values represent mean 6 SEM of 4–5 individually analyzed naphthalene-treated animals per
group compared to the vehicle control group (n = 7) using one-way analysis of variance (ANOVA) with Bonferoni’s post-hoc test. *P,0.05, **P,0.01,
and ***P,0.001. D) Morphometric kinetic analysis demonstrating the relative numbers of CGRPpos, CC10pos, and CC10low cells among the
naphthalene-induced eGFPpos airway-epithelial cells, expressed as average number of cells per mm airway length. Values represent mean 6 SEM of
4–5 individually analyzed naphthalene-treated animals per group at each time point. Note the sequential increase of eGFPpos-CGRPpos, eGFPpos-
CC10lowand eGFPpos-CC10pos cells.
doi:10.1371/journal.pone.0041460.g008
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always localized in the borders between affected and apparently
normal tissue (Figure 9C). We postulate that the cuboidal eGFPpos
cells observed in the early stages of the bleomycin induced
response represent a reparatory progenitor population that
expands and differentiates into the eGFPpos-T1alow cells observed
in the later stages to repair the damaged alveolar epithelium.
Further studies will be required, however, to validate this
hypothesis.
Collectively, our findings demonstrate that the canonical BMP
pathway is re-activated during adult lung injury in a manner that
bears resemblance to the activation of this pathway during early
lung development, strongly supporting its importance during adult
lung tissue injury repair.
Conclusions
Utilizing a transgenic reporter mouse line harboring a BMP-
responsive eGFP reporter allele we were able to construct a
detailed spatiotemporal map of canonical BMP signalling during
early lung development and adult lung tissue injury repair. Our
studies demonstrated that during the pseudoglandular stage, when
branching morphogenesis characterises lung development, canon-
ical BMP pathway is active mainly in the vascular network and the
airway smooth muscle layer. Only after the completion of
branching morphogenesis and the initiation of epithelial cell
differentiation canonical BMP pathway activation commences in
airway and alveolar epithelial cell that are enriched in progenitors
that can form epithelial colonies in Matrigel in-vitro. The BRE-
eGFP reporter is reactivated in mesenchyme-free distal epithelial
buds cultured in Matrigel suggesting that the low reporter activity
in intact lungs is the result of a dynamic interplay between the
endoderm and the mesenchyme and moreover suggest that the
elusive, mesenchyme derived, epithelial growth promoting signal
postulated by Bragg et al. [51] may act by regulating negatively
activation of the canonical BMP pathway in the distal epithelium
buds.
BRE-eGFP expression, in agreement with earlier reports
describing the temporal expression pattern of some BMP pathway
components during late lung development [65], peaks around
birth and returns to very low levels upon completion of lung
development. Remarkably, severe depletion of Clara cells in the
adult lung by naphthalene treatment, leads to re-expression of the
eGFP reporter around NEBs and terminal bronchioles, areas
known to harbour airway progenitor cells. Likewise, injury of the
alveolar epithelium in the adult lung by bleomycin treatment,
leads to re-expression of eGFP initially in SpCpos cuboidal
epithelial cells, which we postulated to be alveolar epithelial
progenitors and subsequently in squamous T1alow cells which we
postulated to be derived from the former population and on the
way to differentiate to Type-I pneumonocytes. Our findings are
compatible with the notion that during the late stages of lung
development the role of canonical BMP signalling pathway is to
maintain the undifferentiated state of the airway and alveolar
epithelial progenitors preventing premature exhaustion of their
pools and securing the continuous supply of the differentiated
epithelial cells that are required for a fully developed lung. The
reactivation of the BMP responsive reporter in adult animals
undergoing repair of severe epithelial injury, where the same
requirements regarding proper management of the undifferenti-
ated epithelial progenitor pools apply, is also compatible with this
conjecture. An analogous function has been previously proposed
for BMP signaling regarding the maintenance of the undifferen-
tiated state of pluripotent mouse embryonic stem (ES) cells [66,67]
Figure 9. The eGFP reporter is reactivated in the alveolar regions of BRE-eGFP transgenic animals after bleomycin treatment. A)
Panoramic picture produced by digitally merging fifty-four 106images from a lung tissue-section of a BRE-eGFP animal analysed four days after intra-
tracheal instillation of bleomycin. Numerous eGFPpos cells are scattered in alveolar regions. B) Representative higher magnification images of BRE-
eGFP transgenics treated with vehicle or bleomycin(days 4 and 12 post-instillation) demonstrating the appearance of eGFPpos alveolar-cells (scale bar:
150 mm. C) Representative confocal images of tissue sections stained for eGFP, SpC and T1a, demonstrating, eGFP expression in SpCpos and
T1alowcells. Scale bar: 25 mm.
doi:10.1371/journal.pone.0041460.g009
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and the maintenance of the undifferentiated, multipotent state of
distal lung progenitor cells [45,68].
The construction of a spatiotemporal map of canonical BMP
signalling during lung development and adult lung tissue injury
repair (summarised in Figure 10 and table S2) will facilitate
interpretation of earlier genetic studies and guide rational targeting
of BMP signaling components in future experiments. Moreover,
the ease isolation of living eGFPpos i.e. BMP responding,
subpopulations of lung cells by cell sorting will greatly facilitate
definitive clarification of the mechanisms of action of this signaling
system during early lung development and repair of lung tissue
injury in the adult.
Supporting Information
Figure S1 Activation of canonical BMP-pathway in
E12.5 lungs. A) Representative confocal images demonstrating
activation of the BRE-eGFP transgene in the vascular network
of the lung in E12 embryos. E12 lung tissues from BRE-eGFP
transgenic animals were stained for eGFP, CD31, VEGFR-2
and aSMA. Nuclei were counterstained with DAPI. The images
demonstrate robust activation of eGFP expression in CD31pos
and VEGFR-2pos cells and week activation in some of the sub-
epithelial aSMApos cells (see insert in lower right image). Of
note is the complete absence of any eGFP staining in the airway
epithelial compartment. B) Kinetics of BRE-eGFP reporter
activation in sub-epithelial smooth muscle cells (CMSs).
Representative confocal images of tissue sections prepared from
E11, E12, E13.5 and E14.5 BRE-eGFP transgenic lungs and
stained for eGFP, SM22a and aSMA. The left panel shows
magnified the eGFP channel only. The white dashed rectangles
in each lane of images correspond to identical tissue areas. Note
that the BRE-eGFP reporter is activated in mature aSMA
positive cells that are located in the most proximal portion of the
airway tree.
(TIF)
Figure S2 Activation of the canonical BMP-pathway in
sub-epithelial smooth muscle cells of the proximal
airways in E14.5 lungs. Representative confocal image of an
E14.5 tissue section stained for eGFP (green staining) and SpC (red
staining). Nuclei were counterstained with DAPI. Only proximal
airways (defined by the very low staining for Pro-SpCare
surrounded by eGFPpos sub-epithelial smooth muscle cells.
(TIF)
Figure S3 FGF10, BMP4 and a Sonic Hedgehog agonist
affect expression of the BRE-eGFP reporter. A) Whole E12
lung-explants were cultured on Nuclepore membranes for eight
hours in the presence of vehicle, FGF10 (250 ng/ml), BMP4
(100 ng/ml) or Sonic Hedgehog agonist Purmorphamin (500 nM).
Upper panel shows bright field images of representative explants.
Lower panel shows eGFP expression in the same explants. B)
Confocal images of tissue sections prepared from the explants
described above stained for eGFP (green stain). Nuclei were
counterstained with DAPI. Note the strong upregulation of eGFP
expression in the FGF10 and BMP4 treated explants, and the
Figure 10. Schematic representation of the spatiotemporal activation pattern of Canonical BMP pathway in the mouse lung.
Summary of canonical BMP-signaling activation in lung development and adult tissue-repair based on the current study and the studies of Monteiro
et al. [33] and Blank et al. [39]. Airways (Aw), airway branch-points (Awbp), blood-vessel (Bv), Airway smooth muscle cells (ASMc), cardiomyocyte-like
cells (CMlc), alveolar regions (Alv). eGFPpos cells are shown green.
doi:10.1371/journal.pone.0041460.g010
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contruction of the eGFP positive zone in the purmorphamine
treated group.
(TIF)
Figure S4 Correlation between pSmad1/5/8 and BRE-
eGFP immune-staining in P1 lung tissue sections.
Adjacent tissue section of lungs from BRE-eGFP reporter animals
were stained with anti-GFP or anti-pSmad1/5/8 antibodies as
described in materials and methods. A) Staining of adjacent
sections of a large airway with anti-GFP and anti pSmad1/5/
8antibodies or normal rabbit IgG fraction as isotype control. B)
Representative images from the indicated tissue regions demon-
strating that tissue areas with intense BRE-eGFP expression
coincide with regions exhibiting pSma1/5/8 immuno-staining.
The scale bar corresponds to 25 mm.
(TIF)
Figure S5 The zone of eGFPposCC10pos cells coincides
with the NEB-rich portion of the airway tree. A) Confocal
image of a lung tissue section derived from a P1 BRE-eGFP
animal stained for eGFP (green staining), CC10 (red staining) and
CGRP (white staining). The images illustrate the zone in the
airway-tree where co-expression of eGFP and CC10 occurs. The
lower images, showing the CGRP and DAPI channels of the upper
images, illustrate the coincidence of eGFPpos-CC10pos zone with
the NEB-rich regions of the airway tree. B) Confocal images of the
transitional zone between the eGFPpos-CC10neg and eGFPneg-
CC10pos domains of the airways demonstrating the preferential
association of eGFPpos-CC10low cells with NEBs. The image
depicting NEBs is obtained from a section sequential to the ones
depicting CC10 and eGFP expression. Nuclei were counterstained
with DAPI (blue staining).
(TIF)
Figure S6 Minimal eGFP expression in the Foxj-1pos
airway ciliated cells. Representative confocal images demon-
strating minimal activation of the BRE-eGFP transgene in
FoxJ1pos ciliated airway epithelial cells. Tissue section collected
from E17.5, E19.5, P1, P15 and adult BRE-eGFP transgenic lungs
were stained for eGFP (green staining), FoxJ1 (red staining) and
CGRP (white staining). Nuclei were counterstained with DAPI
(blue staining). The images demonstrate the presence of remark-
ably low number of eGFPpos-FoxJ1pos epithelial cell (depicted with
yellow arrows).
(TIF)
Figure S7 A small, however, detectable number of BRE-
eGFP developing type-I pneumocytes (T1apos) express
eGFP. Representative confocal images of lung sections of E14.5,
E17.5, E19.5, P1, P15 and adult BRE-eGFP transgenic lungs
stained for eGFP (green staining), CD31 (red staining) and T1a
(white staining). Nuclei were counterstained with DAPI (blue
staining). The Scale bars are 20 mm. The images demonstrate that
whereas the majority of the developing endothelial cells express
eGFP, only a small number of type-I pneumocytes, shown in the
inserts of the P1 and P15 image, are eGFPpos.
(TIF)
Table S1 Primer pairs utilized for quantitative PCR
analysis in the present study. The forward and reverse
primers designed with the Beacon Designer v7.01 software, using
the indicated data-base gene sequences (Ref. sequence) and the
size of the amplicons are indicated.
(DOCX)
Table S2 Summary of the spatiotemporal expression pattern of
the BRE-eGFP reporter during lung development and adult lung
tissue injury repair.
(DOCX)
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